Edesa Biotech Extends Dermatitis Study to Canada

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/27/2026

1. NVDA
2. USO
3. BSP
4. MPLT
5. CAPR
6. SPY
7. XFLT
8. HCA
9. ITG
10. CHTR

Go back to Edesa Biotech Extends Dermatitis Study to Canada
(NASDAQ: EDSA) Delayed: 5.35 +0.10 (1.90%)
Previous Close $5.25    52 Week High $ 
Open $5.35    52 Week Low $ 
Day High $5.52    P/E N/A 
Day Low $5.12    EPS $ 
Volume 89,263